Imatinib alters cell viability but not growth factors levels in TM4 Sertoli cells
{{output}}
Background: The anticancer agent imatinib (IM) is a small molecular analog of ATP that inhibits tyrosine kinase activity of platelet derived growth factors (PDGFs) and stem cell factor (SCF) receptor in cancer cells. However thes... ...
